MELOXICAM TABLETS
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
Defense Logistics Agency award SPE2DP26F9992 is a delivery order issued on September 16, 2026, to DMS Pharmaceutical Group Inc for the procurement of Meloxicam Tablets. This specific order, valued at 45.00 dollars, is placed under the broader basic contract SPE2DX25D9900, which was originally issued by the DLA Troop Support Medical Supply Chain on April 2, 2025, for commercial items with a total award value of 19,999,999.00 dollars. The order specifies the delivery of Meloxicam Tablets, identified by NSN 6505015413243 and PR 7018376819, with shipping terms set as FOB Destination to Fort Bragg, North Carolina. This transaction is part of a larger federal procurement effort managed by the Department of Defense to maintain medical supply chains.
General Info
Contract Value
$45Place of Performance
Not specifiedSet-Aside
Awardee
DMS PHARMACEUTICAL GROUP INCAward Issued Date
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
